Sensus Healthcare (SRTS) Cash from Investing Activities (2017 - 2026)
Sensus Healthcare's (SRTS) quarterly Cash from Investing Activities came in at -$3000.0 in Q1 2026, up 57.14% year-on-year from -$1909.1 in Q1 2025, and up 98.1% quarter-over-quarter from -$158000.0 in Q4 2025.
Sensus Healthcare (SRTS) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Sensus Healthcare's Cash from Investing Activities history runs 10 years deep, the most recent figure standing at -$3000.0 for Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 57.14% year-over-year to -$3000.0 in Q1 2026; TTM through Mar 2026 was -$192000.0, a 284.0% decrease from a year earlier, with the FY2025 full-year figure at -$196000.0, up 28.99% from the prior year.
- Cash from Investing Activities climbed to -$3000.0 in Q1 2026 per SRTS's latest filing, from -$158000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $15.0 million in Q1 2022 and bottomed at -$337000.0 in Q3 2024.
- The 5-year median for Cash from Investing Activities is -$18500.0 (2022), against an average of $886187.5.
- Biggest YoY gain for Cash from Investing Activities was 18795.0% in 2022; the steepest drop was 1900.0% in 2022.
- Year by year, Cash from Investing Activities stood at -$10000.0 in 2022, then surged by 410.0% to $31000.0 in 2023, then jumped by 858.06% to $297000.0 in 2024, then slumped by 153.2% to -$158000.0 in 2025, then surged by 98.1% to -$3000.0 in 2026.
- Per Business Quant, the three latest SRTS Cash from Investing Activities figures stand at -$3000.0 (Q1 2026), -$158000.0 (Q4 2025), and -$4000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -298.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -475.32 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sensus Healthcare | 50.14 Mn | 31.81 Mn | - | -3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -158,000.00 |
| Dec 31, 2025 | -158,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -27,000.00 |
| Jun 30, 2025 | -27,000.00 |
| Mar 31, 2025 | -7,000.00 |
| Mar 31, 2025 | -7,000.00 |
| Dec 31, 2024 | 297,000.00 |
| Dec 31, 2024 | 297,000.00 |
| Sep 30, 2024 | -337,000.00 |
| Sep 30, 2024 | -337,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Mar 31, 2024 | -233,000.00 |
| Mar 31, 2024 | -233,000.00 |
| Sep 30, 2023 | 31,000.00 |
| Sep 30, 2023 | 31,000.00 |